{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:27:01Z","timestamp":1770283621128,"version":"3.49.0"},"reference-count":12,"publisher":"European Respiratory Society (ERS)","issue":"2","content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2018,10,24]]},"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1183\/13993003.01128-2018","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T12:15:23Z","timestamp":1541679323000},"page":"1801128","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of latent tuberculosis with 12\u2005weeks isoniazid\/rifapentine in clinical practice"],"prefix":"10.1183","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0551-0072","authenticated-orcid":false,"given":"Gabrielle","family":"Fr\u00f6berg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Bruchfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"2024102100414935000_53.2.1801128.1","unstructured":"WHO. Implementing the End TB Strategy: the Essentials. Geneva, World Health Organization, 2015."},{"key":"2024102100414935000_53.2.1801128.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01245-2015"},{"key":"2024102100414935000_53.2.1801128.3","doi-asserted-by":"crossref","unstructured":"Zenner D , Loutet MG , Harris R , et\u00a0al. Evaluating 17\u2005years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation. Eur Respir J 2017; 50.","DOI":"10.1183\/13993003.02505-2016"},{"key":"2024102100414935000_53.2.1801128.4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amepre.2018.04.030","article-title":"Isoniazid-rifapentine for latent tuberculosis infection: a systematic review and meta-analysis","volume":"55","author":"Njie","year":"2018","journal-title":"Am J Prev Med"},{"key":"2024102100414935000_53.2.1801128.5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/pds.4423","article-title":"A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection","volume":"27","author":"Pease","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2024102100414935000_53.2.1801128.6","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001098"},{"key":"2024102100414935000_53.2.1801128.7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1513\/AnnalsATS.201704-326OC","article-title":"Exposure to latent tuberculosis treatment during pregnancy. The PREVENT TB and the iAdhere Trials","volume":"15","author":"Moro","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2024102100414935000_53.2.1801128.8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial","volume":"167","author":"Belknap","year":"2017","journal-title":"Ann Intern Med"},{"key":"2024102100414935000_53.2.1801128.9","unstructured":"Folkh\u00e4lsomyndigheten. Rekommendationer f\u00f6r preventiva insatser mot tuberkulos \u2013 h\u00e4lsokontroll, smittsp\u00e5rning, behandling av latent infektion och vaccination [Recommendations for preventative action against tuberculosis \u2013 health checks, infection tracking, treatment of latent infection and vaccination]. Solna, Folkh\u00e4lsomyndigheten, 2017."},{"key":"2024102100414935000_53.2.1801128.10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3109\/0886022X.2013.815567","article-title":"Rifampicin-associated acute renal failure and hemolysis: a rather uncommon but severe complication","volume":"35","author":"Manika","year":"2013","journal-title":"Ren Fail"},{"key":"2024102100414935000_53.2.1801128.11","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2169\/internalmedicine.52.0634","article-title":"Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review","volume":"52","author":"Chiba","year":"2013","journal-title":"Intern Med"},{"key":"2024102100414935000_53.2.1801128.12","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0692"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01128-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:00:43Z","timestamp":1740380443000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01128-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":12,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,7]]},"published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1183\/13993003.01128-2018"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01128-2018","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}